In this study, the phosphorylation of ERK1/2 in the normal and SSc fibroblasts was significantly enhanced by the ARα agonist, oxymetazoline, but not the ARβ agonist, isoproterenol (Fig. 3A,C). Here, BEST1 is linked to systemic sclerosis.